Corcept Therapeutics Inc (CORT)
50.07
+2.45
(+5.14%)
USD |
NASDAQ |
Nov 04, 16:00
50.07
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics 1 Year Total Returns (Daily): 95.43% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 95.43% |
November 01, 2024 | 69.53% |
October 31, 2024 | 74.39% |
October 30, 2024 | 71.57% |
October 29, 2024 | 76.85% |
October 28, 2024 | 77.33% |
October 25, 2024 | 71.86% |
October 24, 2024 | 68.41% |
October 23, 2024 | 76.37% |
October 22, 2024 | 75.21% |
October 21, 2024 | 75.90% |
October 18, 2024 | 75.86% |
October 17, 2024 | 66.50% |
October 16, 2024 | 68.28% |
October 15, 2024 | 69.96% |
October 14, 2024 | 64.37% |
October 11, 2024 | 64.66% |
October 10, 2024 | 65.21% |
October 09, 2024 | 72.45% |
October 08, 2024 | 73.41% |
October 07, 2024 | 69.17% |
October 04, 2024 | 75.41% |
October 03, 2024 | 72.11% |
October 02, 2024 | 74.44% |
October 01, 2024 | 71.59% |
Date | Value |
---|---|
September 30, 2024 | 69.87% |
September 27, 2024 | 35.71% |
September 26, 2024 | 33.29% |
September 25, 2024 | 31.62% |
September 24, 2024 | 39.06% |
September 23, 2024 | 35.75% |
September 20, 2024 | 31.87% |
September 19, 2024 | 24.11% |
September 18, 2024 | 30.79% |
September 17, 2024 | 18.64% |
September 16, 2024 | 14.94% |
September 13, 2024 | 13.36% |
September 12, 2024 | 8.11% |
September 11, 2024 | 7.60% |
September 10, 2024 | 6.34% |
September 09, 2024 | 5.34% |
September 06, 2024 | 9.04% |
September 05, 2024 | 7.74% |
September 04, 2024 | 4.59% |
September 03, 2024 | 3.50% |
August 30, 2024 | 7.39% |
August 29, 2024 | 7.04% |
August 28, 2024 | 6.89% |
August 27, 2024 | 9.23% |
August 26, 2024 | 10.31% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-42.58%
Minimum
Jan 27 2022
152.2%
Maximum
Mar 16 2021
23.49%
Average
15.78%
Median
1 Year Total Returns (Daily) Benchmarks
ADMA Biologics Inc | 423.6% |
Akebia Therapeutics Inc | 95.26% |
Bioventus Inc | 257.0% |
Alnylam Pharmaceuticals Inc | 61.30% |
Catalyst Pharmaceuticals Inc | 65.20% |